NRX Pharmaceuticals (NRXP) Invested Capital (2021 - 2025)
NRX Pharmaceuticals' (NRXP) quarterly Invested Capital came in at $152000.0 in Q3 2025, down 76.03% year-on-year from $634000.0 in Q3 2024, and down 59.79% on a QoQ basis from $378000.0 in Q2 2025.
NRX Pharmaceuticals (NRXP) Invested Capital (2021 - 2025) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 4 years of Invested Capital data on file, last reported at $152000.0 in Q3 2025.
- On a quarterly basis, Invested Capital fell 76.03% year-over-year to $152000.0 in Q3 2025; TTM through Mar 2026 was $530000.0, a 72.06% decrease from a year earlier, with the FY2024 full-year figure at $320000.0, changed N/A from the prior year.
- Invested Capital for Q3 2025 stood at $152000.0, down from $378000.0 in the prior quarter.
- Over the last five years, Invested Capital for NRXP reached as high as $26.3 million in Q3 2021 and fell as low as $152000.0 in Q3 2025.
- Historically, Invested Capital has averaged $6.8 million across 4 years, with a median of $943000.0 in 2024.
- On a YoY basis, Invested Capital climbed as much as 59.92% in 2025 and fell as far as 76.03% in 2025.
- Year by year, Invested Capital stood at $4.6 million in 2021, then plunged by 45.9% to $2.5 million in 2022, then sank by 87.09% to $320000.0 in 2024, then tumbled by 52.5% to $152000.0 in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $152000.0 in Q3 2025, $378000.0 in Q2 2025, and $320000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 943,000.00 |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Sep 30, 2021 | 26.28 Mn |
| Jun 30, 2021 | 25.87 Mn |